Growth Metrics

Biohaven (BHVN) Cash from Investing Activities (2021 - 2026)

Biohaven has reported Cash from Investing Activities over the past 6 years, most recently at $15.2 million for Q1 2026.

  • Quarterly results put Cash from Investing Activities at $15.2 million for Q1 2026, down 90.77% from a year ago — trailing twelve months through Mar 2026 was $150.9 million (up 232.22% YoY), and the annual figure for FY2025 was $300.6 million, up 222.69%.
  • Cash from Investing Activities reached $15.2 million in Q1 2026 per BHVN's latest filing, up from -$13.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $165.0 million in Q3 2025 and bottomed at -$264.0 million in Q4 2022.
  • Median Cash from Investing Activities over the past 5 years was -$3.9 million (2023), compared with a mean of -$6.1 million.
  • The largest annual shift saw Cash from Investing Activities crashed 131251.24% in 2022 before it skyrocketed 3313.5% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$264.0 million in 2022, then surged by 98.52% to -$3.9 million in 2023, then crashed by 2140.06% to -$87.7 million in 2024, then soared by 84.33% to -$13.7 million in 2025, then surged by 210.72% to $15.2 million in 2026.
  • Business Quant data shows Cash from Investing Activities for BHVN at $15.2 million in Q1 2026, -$13.7 million in Q4 2025, and $165.0 million in Q3 2025.